These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29302031)

  • 1. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche.
    Guarnerio J; Mendez LM; Asada N; Menon AV; Fung J; Berry K; Frenette PS; Ito K; Pandolfi PP
    Nat Commun; 2018 Jan; 9(1):66. PubMed ID: 29302031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
    Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
    Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells.
    Agarwal P; Isringhausen S; Li H; Paterson AJ; He J; Gomariz Á; Nagasawa T; Nombela-Arrieta C; Bhatia R
    Cell Stem Cell; 2019 May; 24(5):769-784.e6. PubMed ID: 30905620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling.
    Agarwal P; Li H; Choi K; Hueneman K; He J; Welner RS; Starczynowski DT; Bhatia R
    Cell Rep; 2021 Jul; 36(2):109386. PubMed ID: 34260914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
    Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
    Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.
    Hamilton A; Helgason GV; Schemionek M; Zhang B; Myssina S; Allan EK; Nicolini FE; Müller-Tidow C; Bhatia R; Brunton VG; Koschmieder S; Holyoake TL
    Blood; 2012 Feb; 119(6):1501-10. PubMed ID: 22184410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
    Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
    Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
    Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
    Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling.
    Himburg HA; Roos M; Fang T; Zhang Y; Termini CM; Schlussel L; Kim M; Pang A; Kan J; Zhao L; Suh H; Sasine JP; Sapparapu G; Bowers PM; Schiller G; Chute JP
    J Clin Invest; 2020 Jan; 130(1):315-328. PubMed ID: 31613796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
    Spencer A; Granter N
    Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.
    Kobayashi CI; Takubo K; Kobayashi H; Nakamura-Ishizu A; Honda H; Kataoka K; Kumano K; Akiyama H; Sudo T; Kurokawa M; Suda T
    Blood; 2014 Apr; 123(16):2540-9. PubMed ID: 24574458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
    Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
    Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
    Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
    Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
    Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
    Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.
    Morotti A; Torti D; Carra G; Panuzzo C; Crivellaro S; Taulli R; Fava C; Guerrasio A; Saglio G
    Curr Drug Targets; 2017; 18(4):389-395. PubMed ID: 27291926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.
    Krause DS; Lazarides K; Lewis JB; von Andrian UH; Van Etten RA
    Blood; 2014 Feb; 123(9):1361-71. PubMed ID: 24394666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice.
    Chen Y; Hu Y; Michaels S; Segal D; Brown D; Li S
    Leukemia; 2009 Aug; 23(8):1446-54. PubMed ID: 19322212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.
    Sengupta A; Arnett J; Dunn S; Williams DA; Cancelas JA
    Blood; 2010 Jul; 116(1):81-4. PubMed ID: 20407032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
    Chen Y; Sullivan C; Peng C; Shan Y; Hu Y; Li D; Li S
    Blood; 2011 Jul; 118(2):390-400. PubMed ID: 21596859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.